TAKEDA PHARMACEUTICAL CO LTD files 6-K

Takeda Pharmaceutical Company Limited's 150th Annual General Meeting of Shareholders approved the appropriation of surplus, including a year-end dividend of 100 JPY per share. The meeting also approved the election of new and re-elected directors.